Eligibility Chronic Kidney Disease NCT00641589

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with a glomerular filtration rate (gfr) within 15-60 ml/min/1.73m2 and stable creatinine over the past 6 months and no expected need for dialysis during the study
Beskrivning

Glomerular filtration rate

Datatyp

boolean

Alias
UMLS CUI [1]
C0017654
patients with a hemoglobin (hg) < 11 g/dl at screening
Beskrivning

Hemoglobin

Datatyp

boolean

Alias
UMLS CUI [1]
C0019046
patients with a transferrin saturation >= 20% or a ferritin >= 50 ng/ml.
Beskrivning

Transferrin saturation or ferritin

Datatyp

boolean

Alias
UMLS CUI [1]
C1277709
UMLS CUI [2]
C0015879
patients who have not received any erythropoietic agents within 6 weeks prior to the first study dose
Beskrivning

Erythropoietic agents

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0312829
UMLS CUI [1,2]
C0013216
patients with reproductive potential must have a negative b-hcg pregnancy test within 14 days of the first dose of study drug and a negative urine pregnancy test on the day of the first dose of study drug
Beskrivning

Pregnancy test

Datatyp

boolean

Alias
UMLS CUI [1]
C0032976
patients and their partners must be practicing an effective method of birth control before entry and throughout the study
Beskrivning

Contraception

Datatyp

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
exclusion criteria include but are not limited to the following: patients with significant hematological disease (disorders of the blood and blood forming tissues
Beskrivning

Hematological disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0018939
including but not limited to myelodysplastic syndrome, hematological malignancy, hemolytic syndromes, hemoglobinopathy)
Beskrivning

Myelodysplastic syndrome, hematological malignancy, hemolytic syndromes, hemoglobinopathy

Datatyp

boolean

Alias
UMLS CUI [1]
C3463824
UMLS CUI [2]
C0376545
UMLS CUI [3]
C2945560
UMLS CUI [4]
C0019045
patients with liver function test results > 2 or more times the normal value
Beskrivning

Liver function test

Datatyp

boolean

Alias
UMLS CUI [1]
C0023901
patients with new onset seizures (within the last 3 months) or seizures not controlled by medication prior to admission in to the study
Beskrivning

Seizures

Datatyp

boolean

Alias
UMLS CUI [1]
C0036572
patients with a history of thrombotic vascular events (including by not limited to acute myocardial infarction (ami) within the previous 6 months, stroke, transient ischemic attack (tia), deep vein thrombosis,(dt) and pulmonary embolism (pe)
Beskrivning

Thrombotic vascular events

Datatyp

boolean

Alias
UMLS CUI [1]
C1869077
patients with poorly controlled or uncontrolled hypertension
Beskrivning

Uncontrolled hypertension

Datatyp

boolean

Alias
UMLS CUI [1]
C1868885
patients with anemia due to blood loss.
Beskrivning

Anemia due to blood loss

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0002871
UMLS CUI [1,2]
C3163616

Similar models

Eligibility Chronic Kidney Disease NCT00641589

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Glomerular filtration rate
Item
patients with a glomerular filtration rate (gfr) within 15-60 ml/min/1.73m2 and stable creatinine over the past 6 months and no expected need for dialysis during the study
boolean
C0017654 (UMLS CUI [1])
Hemoglobin
Item
patients with a hemoglobin (hg) < 11 g/dl at screening
boolean
C0019046 (UMLS CUI [1])
Transferrin saturation or ferritin
Item
patients with a transferrin saturation >= 20% or a ferritin >= 50 ng/ml.
boolean
C1277709 (UMLS CUI [1])
C0015879 (UMLS CUI [2])
Erythropoietic agents
Item
patients who have not received any erythropoietic agents within 6 weeks prior to the first study dose
boolean
C0312829 (UMLS CUI [1,1])
C0013216 (UMLS CUI [1,2])
Pregnancy test
Item
patients with reproductive potential must have a negative b-hcg pregnancy test within 14 days of the first dose of study drug and a negative urine pregnancy test on the day of the first dose of study drug
boolean
C0032976 (UMLS CUI [1])
Contraception
Item
patients and their partners must be practicing an effective method of birth control before entry and throughout the study
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hematological disease
Item
exclusion criteria include but are not limited to the following: patients with significant hematological disease (disorders of the blood and blood forming tissues
boolean
C0018939 (UMLS CUI [1])
Myelodysplastic syndrome, hematological malignancy, hemolytic syndromes, hemoglobinopathy
Item
including but not limited to myelodysplastic syndrome, hematological malignancy, hemolytic syndromes, hemoglobinopathy)
boolean
C3463824 (UMLS CUI [1])
C0376545 (UMLS CUI [2])
C2945560 (UMLS CUI [3])
C0019045 (UMLS CUI [4])
Liver function test
Item
patients with liver function test results > 2 or more times the normal value
boolean
C0023901 (UMLS CUI [1])
Seizures
Item
patients with new onset seizures (within the last 3 months) or seizures not controlled by medication prior to admission in to the study
boolean
C0036572 (UMLS CUI [1])
Thrombotic vascular events
Item
patients with a history of thrombotic vascular events (including by not limited to acute myocardial infarction (ami) within the previous 6 months, stroke, transient ischemic attack (tia), deep vein thrombosis,(dt) and pulmonary embolism (pe)
boolean
C1869077 (UMLS CUI [1])
Uncontrolled hypertension
Item
patients with poorly controlled or uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Anemia due to blood loss
Item
patients with anemia due to blood loss.
boolean
C0002871 (UMLS CUI [1,1])
C3163616 (UMLS CUI [1,2])